ABVX   $6.38  -4.49% Market Closed After Close 6.4 0.31%

Abivax SA

Current temperature: 6.17
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 6
Target Price Mean 35
Mean unverified/preliminary 35 / 35
Target Price Low / High 16 / 50
Median / STD DEV 37 / 14.19
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy ActivelyBuy
rsi ActivelyBuy ActivelyBuy None
macd Sell None None
stoch Sell None None
ma20 Sell Sell None
ma50 Sell None None
ma100 Buy ActivelyBuy ActivelyBuy
Candlestick PatternDec. 30, 2024 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US00370M1036
ceo Mr. Marc M. P. de Garidel M.B.A.
Website https://www.abivax.com
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.